What question did this study set out to answer?

The central aim is to improve the anticancer potential of carminic acid using an innovative nanocarrier approach.

February 19, 2026New Journal of Chemistry0 citations

Enhancing carminic acid anticancer potential: transforming a conventional nanocarrier to a multifunctional therapeutic nanoplatform for photodynamic ROS generation and FRET-based tracking

Q: What is the clinical evidence from this study?

Study design: Other. Intervention: Carminic acid (CA) loaded folic acid modified mesoporous silica nanoparticles (CA@FA-MSNs) vs. Free carminic acid (CA) and other nanoparticle formulations. Primary outcome: In vitro cytotoxicity against HeLa cancer cells after UVB irradiation.

FBFatemeh BahadoraniIsfahan University of Technology HHHassan HadadzadehIsfahan University of Technology SMSeyede Zohreh Mirahmadi-Zare

Resultado clave

CA@FA-MSNs demonstrated enhanced cytotoxicity in HeLa cancer cells compared to free CA and other nanocarriers after UVB irradiation.

Puntos clave

The central aim is to improve the anticancer potential of carminic acid using an innovative nanocarrier approach.
Evaluated the efficacy of carminic acid in a modified nanocarrier system.
Assessed photodynamic reactive oxygen species generation.
Implemented FRET techniques for tracking therapeutic effects.
The multifunctional nanocarrier significantly increased carminic acid's anticancer effects.
Enhanced tumor selectivity was reported compared to conventional chemotherapy agents.
Improved tracking of therapeutic action was achieved using FRET methods.

PICO estructurado

Intervención

Carminic acid in a multifunctional therapeutic nanoplatform

Resultado

Photodynamic ROS generation and FRET-based tracking

This preclinical study evaluates a carminic acid nanoplatform for anticancer therapy, motivated by the need to avoid cardiotoxicity associated with conventional agents like doxorubicin.

Limitaciones

Study was conducted in vitro with HeLa cell line; no clinical trial or in vivo data available.
No quantitative clinical outcome measures or statistics reported.
Small sample size and single cancer cell line limits generalizability.

Resumen

Conventional chemotherapy agents such as doxorubicin are frequently constrained by poor tumor selectivity and severe adverse effects, including cardiotoxicity. In this study, we evaluate the natural anthraquinone compound carminic acid...

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Bahadorani et al. (Thu,) reported a other. Carminic acid (CA) loaded folic acid modified mesoporous silica nanoparticles (CA@FA-MSNs) vs. Free carminic acid (CA) and other nanoparticle formulations was evaluated on In vitro cytotoxicity against HeLa cancer cells after UVB irradiation. CA@FA-MSNs demonstrated enhanced cytotoxicity in HeLa cancer cells compared to free CA and other nanocarriers after UVB irradiation.

synapsesocial.com/papers/6996a7c3ecb39a600b3edc7d https://doi.org/https://doi.org/10.1039/d5nj04468e

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo